# Acurable

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/acurable

- Industry: Medical Devices & Equipment
- Headquarters: London, UK
- Website: www.acurable.com
- Total disclosed funding: $12M
- Latest round: Series A (Jun 30, 2022)
- Investors on record: 4

## About

Acurable Ltd innovates wearable medical devices, notably the AcuPebble Ox100, an FDA-cleared device designed for at-home testing of obstructive sleep apnea and other chronic conditions.Founded in 2016, Acurable Ltd is based in London, UK, and specializes in wearable medical technology. The company's founders include Anas Imtiaz, Emilio Sanz, Esther Rodriguez-Villegas, and Stuart Bowyer, with Emilio Sanz currently serving as CEO. In June 2022, Acurable raised GBP 7.78 million in a Series A funding round led by Kibo Ventures, with participation from Comprador Holdings and other investors. The company has successfully completed 2 deals to date and is currently valued at GBP 27.845 million.Acurable specializes in innovative wearable medical devices, primarily focusing on the AcuPebble Ox100, which is an FDA-cleared home sleep testing device for obstructive sleep apnea (OSA). This technology utilizes advanced sensing and physiological monitoring methods to capture and analyze internal body sounds related to respiratory and cardiac functions. The device wirelessly transmits data to a mobile device for diagnosis and management of chronic conditions such as sleep apnea, epilepsy, COPD, and asthma. Acurable's clientele includes healthcare providers and organizations like the NHS in the UK, and its products are marketed chiefly in the US, UK, and Spain.Acurable generates revenue through direct sales of its wearable medical devices, particularly the AcuPebble Ox100, designed for home use. Sales transactions occur mainly between Acurable and healthcare providers, enhancing diagnostic capabilities for sleep-related disorders. The company may also form partnerships with healthcare institutions to broaden its service delivery, although specific pricing details for its products are not disclosed.In June 2022, Acurable Ltd raised GBP 7.78 million in Series A funding to support its strategic focus on global market expansion and further development of its product offerings. The company is planning to introduce new products aimed at enhancing its technological capabilities, while also targeting expansion into new geographic regions. Acurable aims to leverage its recent funding to broaden its reach and improve its service delivery in the coming years.

## Funding rounds

- Series A, Jun 30, 2022, $9.4M — Kibo Ventures, Kindred Capital, Mundi Ventures, Comprador Holdings
- Seed, Jun 30, 2017, $2.7M — Kindred Capital, Mundi Ventures

## Investors

- Kindred Capital (https://capitalatlas.ai/funds/kindred-capital) — Seed, Series A
- Mundi Ventures (https://capitalatlas.ai/funds/mundi-ventures) — Seed, Series A
- Kibo Ventures (https://capitalatlas.ai/funds/kibo-ventures) — Series A
- Comprador Holdings — Series A